retatrutide oral administration (RETA) is one of the most promising investigational peptides in obesity research—but one important question deserves more attention: Can it affect birth control? Current evidence shows that GLP-1 receptor agonists slow Starting dose of retatrutide: the
Description
In April 2026, AHIP reported that leading health plans have already eliminated 11 percent of prior authorizations, representing 6.5 million fewer PA requests for patients

For most users, this defeats the purpose of efficient and easy peptide use

Studies also raised important questions about the long-term value and sustainability, particularly when these drugs can cost more than $1,000 per month

Approximately 60% of Armed Forces members regularly take dietary supplements due to the physical and cognitive demands of military service
& Shimada, S

However, information on employer plan formularies is not publicly available
)